- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/20 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
Patent holdings for IPC class C07D 251/20
Total number of patents in this class: 30
10-year publication summary
2
|
2
|
2
|
1
|
3
|
0
|
3
|
2
|
0
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bayer Cropscience AG | 2042 |
7 |
BASF SE | 20912 |
2 |
University of Kentucky Research Foundation | 687 |
2 |
Cv6 Therapeutics (NI) Limited | 32 |
2 |
Panasonic Holdings Corporation | 1734 |
2 |
Merck KGAA | 2494 |
1 |
Panasonic Corporation | 20128 |
1 |
Bayer AG | 3332 |
1 |
Bayer Intellectual Property GmbH | 2501 |
1 |
DSM IP Assets B.V. | 5595 |
1 |
University of Southern California | 2115 |
1 |
Medical Technology Research Inc. | 6 |
1 |
OM Pharma | 42 |
1 |
Shandong New Time Pharmaceutical Co., Ltd. | 42 |
1 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
1 |
Tosoh Corporation | 1283 |
1 |
Toyo Ink SC Holdings Co., Ltd. | 465 |
1 |
Toyocolor Co., Ltd. | 216 |
1 |
Dow Advanced Display Materials Ltd | 17 |
1 |
Sanofi | 4040 |
1 |
Other owners | 0 |